Blue Square Market Issues Voluntary Nationwide Recall of Kaboom Action Strips and Lida Daidaihua Due to the Presence Of Undeclared Sulfoaildenafil, Sibutramine And Phenolphthalein

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

Blue Square Market Issues Voluntary Nationwide Recall of Kaboom Action Strips and Lida Daidaihua Due to the Presence Of Undeclared Sulfoaildenafil, Sibutramine And Phenolphthalein

08/07/2015 12:18 PM EDT

Blue Square Market Inc. of North Huntingdon, PA, is recalling "Kaboom Actions Strip 12 Pack" and LiDa DaiDaiHua to the user level after FDA analysis revealed the products contain undeclared active pharmaceutical ingredients. Kaboom was found to contain sulfoaildenafil and LiDa DaiDaiHua was found to contain sibutramine and phenolphthalein. Sibutramine is an appetite suppressant that was withdrawn from the U.S. market in October 2010 due to increased risk of heart attacks and strokes. Phenolphthalein is an ingredient previously used in over-the-counter laxatives, but because of concerns of carcinogenicity, it is not currently approved for marketing in the United States.

. For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? Please visit subscriberhelp.govdelivery.com
• Other inquiries? webmail@oc.fda.gov

---

This email was sent to filter@clubhouseb.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420